We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Microsaic Systems Plc | LSE:MSYS | London | Ordinary Share | GB00BMWC8365 | ORD GBP0.00001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.05 | 1.00 | 1.10 | 1.05 | 1.0119 | 1.05 | 163 | 08:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Components, Nec | 1.57M | -2.29M | -0.0128 | -0.82 | 1.88M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/7/2018 16:17 | Sub this sub that is the curse of MM. Whenever the parasite appears on a thread desperately ramping in his cut and paste style. You know a share is doomed!!! and he just wants to minimise his losses and get out. Does it on many boards. Complete looser lol | stephen2010 | |
24/7/2018 14:31 | Stephen, Do me a favour, let MM ramp if he wants to as I know he flips in and out of this share, but don't encourage him and also please refrain from posting sub this , sub that! Ta | k1ngkonggb | |
20/7/2018 16:00 | Just had a small top up showing on Nex, enough to move the bid up, they were paying 1.9p earlier in the week | dave4545 | |
20/7/2018 15:47 | Lol , the only dog here is you mate, a mangy one at that....Microsaic's time will come. ;-) | moneymunch | |
20/7/2018 14:49 | Another dog this muppet monkey nuts is trying...and failing to ramp. Everyone knows what you are now you scammer | sb888 | |
20/7/2018 14:26 | Microsaic @Microsaic 5h5 hours ago Its class-time for learning the powerful benefits for point of need MS #Taiwan #Rightek | moneymunch | |
18/7/2018 18:44 | Microsaic @Microsaic 7h7 hours ago Great to be working with our partners, Rightek, in Taiwan. "Look, no external pumps!", truly bench-top Mass Detection, at the point of need. @Microsaic’s Tweet: | moneymunch | |
18/7/2018 10:11 | I'm expecting this to multi-bag long before then kk, confirmation of successful technology trials and productisation and commercialisation with their global biopharma will do it, and every chance of other game changing news while we're waiting that could also add significant value...Sooner or later....:-) | moneymunch | |
18/7/2018 09:51 | MM, Sales revenue will no doubt ramp up as a result of these distribution agreements, but by how much, is another factor. The market is probably waiting on game changing news as you have already alluded to and I doubt this will be the only major news. The timescales are some way off, so allow for at least 12-18 months but obviously we hope that revenue will be significantly ahead from last year. The company are forecasting annualised revenues of £17-£20m from 2022, and that's when we will start seeing a massive rerate. It could be sooner, as the big biopharma commercialisation (if successful), will certainly dictate the share price | k1ngkonggb | |
18/7/2018 09:46 | News on the potential game changing product commercialisation with their global biopharma partner isn't expected until later in the year and so the timing is obviously a factor, and the market also wants confirmation of Improved sales revenues....and so the six distribution agreements secured this year ( and more to follow ) will also take time before increased product sales can be dilvered and confirmed, and so at the moment the market isn't taking Microsaic's prospects and potential into account imho, and investor interest is focussed elsewhere for the time being....and so the current share price offers a tremendous opportunity to accumulate at a bargain rockbottom low....sooner or later this WILL go BIG TIME!!! GL ;-) | moneymunch | |
18/7/2018 09:25 | Moneymunch, I agree with what you say. The way that the share price is languishing is unfathomable. A start up company with just a concept will be valued more than this. Something is not right somewhere, but I cannot pinpoint what it is. | kingston78 | |
18/7/2018 06:34 | Sooner or later this is going to go BIG TIME.....i picked up 297k plus at 1.68p on yesterdays drop......Cheap as chips......Msys have just raised £5.5m cash, investment company Unicorn Aim VCT took 75m shares 16.43%, a sure sign of confidence....... Six worldwide OEM distribution agreements have been secured since January, with more to come no doubt, and of course we've still got the BIG one to come later this year, a game changing update on the product systems integration phase with their global biopharma partner, a which is expected to lead to product commercialisation. Gla holders.....a major re-rate awaits from this rock bottom bargain low....On and UP!!! ;-) | moneymunch | |
17/7/2018 23:23 | Last one out turn the lights off!!! | stephen2010 | |
16/7/2018 13:24 | I bought some back today, seems to be some good nibbles constantly here. Now if they can clear the line of stock the mm has it might have a spike | dave4545 | |
16/7/2018 09:55 | Ps Buys listed as sells this morning...FILL YA BOOTS!!! Imho...Gla holders:-) | moneymunch | |
13/7/2018 10:03 | The first phase of the collaboration with their global biopharma partner, the feasibility study, lasted 7 to 8 months from April 2017 until confirmation by Rns 13/12/17 that the collaboration agreement had been extended for product integration with their partner's equipment and for further validation by their partner's BIG pharma end users, and so we're already 7 plus months into this phase from the last update...and so an update on proceedings, could be very close.....Tick Tock Boom.....Gla holders;-) December 2017 Q1: Microsaic recently announced the signing of a research agreement with a global partner in biopharma, can you tell us a little bit more about that? A1: Yes, absolutely so Ive got to say that we are under strict NDA in this particular case but what I can do is give you some context. Earlier in the year we successfully completed a significant joint feasibility phase to show dedicated at-line mass spec can assess the quality of biologics during the manufacture. I think perhaps the most important aspect of that phase was that we had substantial end-user validation from big pharma and just to say that these are end-users whom our partner has very good global reach. What this new phase is it will bring more end-user validation to the approach, but I think the exciting deliverable is that we'll be able to provide a lot more technical integration with the partners product. So, should this activity be successful, it will take us into the second half of 2018 and then that will proceed a period of productisation. As I said, I can't give any details yet about the size and timeline for commercialisation, but the opportunity is significant to us, to Microsaic, and delivery is proportionate, I would say, to our timescales. | moneymunch | |
05/7/2018 18:12 | Its all about the placing. Once we start to see where the money is to be spent we should start to move again. Patience needed here for a while | splatted | |
05/7/2018 10:21 | Any chance we could see the share price actually go up as this is getting a tad ridiculous. | k1ngkonggb |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions